Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial
<p>Abstract</p> <p>Background</p> <p>Treatment options for patients with advanced hepatocellular carcinoma (HCC) are often limited. In most cases, they are not amenable to local therapies including surgery or radiofrequency ablation. The multi-kinase inhibitor sorafenib...
Main Authors: | Jäkel Oliver, Burkholder Iris, Edler Lutz, Schmidt Jan, Ganten Tom, Habermehl Daniel, Combs Stephanie E, Haberer Thomas, Debus Jürgen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-02-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/67 |
Similar Items
-
Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial
by: Unterberg Andreas, et al.
Published: (2010-11-01) -
Randomised phase I/II study to evaluate <it>c</it>arbon <it>i</it>o<it>n </it>ra<it>d</it>ioth<it>e</it>rapy ve<it>r</it>sus fractionat<it>e</it>d stereotactic radiotherapy in patients with recurrent or progressive g<it>l</it>iom<it>a</it>s: The CINDERELLA trial
by: Haselmann Renate, et al.
Published: (2010-10-01) -
Prometheus
Published: (2023-11-01) -
Prometheus
Published: (2022-05-01) -
Prometheus
Published: (2022-11-01)